In New York, genomic data analysis platforms from Seven Bridges and SolveBio have been integrated with each other to provide expanded capabilities to clients. While financial terms of the agreement were not publicly available, Seven Bridges raised $45 million and SolveBio raised $4.5 million in financing earlier this year. The Seven Bridges platform allows the analysis of millions of genomes with other data. Their clients include the Children’s Hospital of Philadelphia, the VA’s Million Veteran Program, and the National Cancer Institute. SolveBio’s platform allows the indexing and linking of biomarkers and variant data. Now with both platforms integrated, clients can analyze large genomic datasets using Seven Bridges and connect that information to SolveBio for interpretation and assessments.
Latest article
You better be-leaf it: Dawn Bio cultivates wood in a petri dish
In the Netherlands, a startup based at Wageningen University’s campus is pioneering technology to produce wood from cultured cells.
Dubbed Dawn Bio, the company has...
Algae-based snowboards from WNDR get nod from Time Magazine
In Utah, WNDR Alpine’s algae-based snowboards have been named to Time Magazine’s top 200 inventions list.
Unlike most snowboards, which are made out of petroleum-based...
Prince William’s Earthshot Prize names seaweed firm Coast 4C as a finalist
In Australia, a startup sustainably cultivating seaweed has been chosen as a finalist for Prince William’s 2024 Earthshot Prize.
Coast 4C works with farmers in...